Effectiveness of Osteopathic Manipulative Treatment in Pediatric Asthma

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01853189

Acronym

OMT

Enrollment

150

Registered

2013-05-14

Start date

2014-11-30

Completion date

2015-12-31

Last updated

2014-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

pediatrics, asthma, osteopathic manipulative treatment

Brief summary

Asthma is a highly prevalent chronic disease in children. Complementary and Alternative Medicine research on asthma showed a potential effect on pediatric patients. Studies looking at the effect of Osteopathic Manipulative Treatment seems to reveal positive results. The aim of study is to further explore the role of OMT on asthma in a pediatric population.

Interventions

OTHERUsual Care

patients from control group received standard care + osteopathic evaluation only, according to the same schedule of the study group

OTHEROMT + Usual Care

patients from this group received 6 sessions of OMT

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

5 Years to 14 Years

Healthy volunteers

Inclusion criteria

* children with asthma age between 5 and 14

Exclusion criteria

* associated co-morbities surgical patients

Design outcomes

Primary

Measure	Time frame
Difference in Forced expiratory volume in the 1st second (FEV1) before and after OMT	Participants will be assessed at entry, after 3 and 6 months.

Secondary

Measure	Time frame
Difference in fractional exhaled nitric oxide (FeNO) before and after OMT	Participants will be assessed at entry, after 3 and 6 months.
Difference in percentage of hemoglobin saturation before and after OMT	Participants will be assessed at entry, after 3 and 6 months.
Difference in Pediatric Asthma Quality of Life Questionnaire (PAQOL) before and after OMT	Participants will be assessed at entry, after 3 and 6 months.
Differences in the number, type and quality of somatic dysfunctions	Participants will be assessed at entry, after 3 and 6 months
Difference in peak expiratory flow (PEF) before and after OMT	Participants will be assessed at entry, after 3 and 6 months.

Countries

Italy

Contacts

Primary ContactFrancesco Cerritelli, MS, DO

francesco.cerritelli@ebom.it+393394332801

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026